Top

Published in:

01-09-2017 | PROCEEDINGS OF THE 2017 NORTH AMERICAN SOCIETY OF HEAD AND NECK PATHOLOGY COMPANION MEETING (SAN ANTONIO, TX)

OSPs and ESPs and ISPs, Oh My! An Update on Sinonasal (Schneiderian) Papillomas

Author: Justin A. Bishop

Published in: Head and Neck Pathology | Issue 3/2017

Abstract

Sinonasal (Schneiderian) papillomas are benign neoplasms that arise in the sinonasal tract. Since their initial descriptions, sinonasal papillomas have triggered debate regarding their classification, etiology, rate or predictors of malignant transformation, and other issues. While significant strides have been made in recent years, there are still aspects of sinonasal papillomas that remain unclear even now. This review will serve to update the practicing pathologist on the current understanding of sinonasal papillomas.

Barnes L. Schneiderian papillomas and nonsalivary glandular neoplasms of the head and neck. Mod Pathol. 2002;15:279–97.CrossRefPubMed

Hyams VJ. Papillomas of the nasal cavity and paranasal sinuses. A clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol. 1971;80:192–206.CrossRefPubMed

Ash JE, Beck MR, Wilkes JD. Epithelial papilloma. Tumors of the upper respiratory tract and ear. Washington, D.C.: Armed Forces Institute of Pathology; 1964. p. 32–34.

Lampertico P, Russell WO, Maccomb WS. Squamous papilloma of upper respiratory epithelium. Arch Pathol. 1963;75:293–302.PubMed

Barnes L, Bedetti C. Oncocytic Schneiderian papilloma: a reappraisal of cylindrical cell papilloma of the sinonasal tract. Hum Pathol. 1984;15:344–51.CrossRefPubMed

Hyams VJ, Batsakis JG, Michaels L. Papilloma of the sinonasal tract. Tumors of the upper respiratory tract and ear. Washington, D.C.: Armed Forces Institute of Pathology; 1988. p. 34–44.

Mills SE, Gaffey MJ, Frierson HF Jr. Schneiderian papillomas. Tumors of the upper respiratory tract and ear. Washington, D.C.: Armed Forces Institute of Pathology; 2000. p. 21–9.

Mills SE, Stelow EB, Hunt JL. Schneiderian papillomas. Tumors of the upper aerodigestive tract and ear. Washington, D.C.: American Registry of Pahtology; 2012. pp. 22–30.

Barnes L, Tse LLY, Hunt JL. Schneiderian papillomas. In: Barnes L, Eveson JW, Reichart P et al, editors. World health classification of tumors: head and neck. Lyon: IARC Press; 2005. p. 28–32.

10.

Hunt JL, Bell D, Sarioglu S. Sinonasal papilloma, inverted type. In: el-Naggar A, Slootweg PJ, Chan JKC et al, editors. World health classification of tumors: head and neck. Lyon: IARC Press; 2017. p. 18–9.

11.

Hunt JL, Chiosea S, Sarioglu S. Sinonasal papilloma, oncocytic type. In: el-Naggar A, Slootweg PJ, Chan JKC et al, editors. World Health Classification of Tumors: Head and Neck. Lyon: IARC Press; 2017. p. 19–20.

12.

Hunt JL, Lewis JS, Richardson M, et al. Sinonasal papilloma, exophytic type. In: el-Naggar A, Slootweg PJ, Chan JKC et al, editors. World health classification of tumors: head and neck. Lyon: IARC Press; 2017. p. 20–1.

13.

Bullock MJ. Low-grade epithelial proliferations of the sinonasal tract. Head Neck Pathol. 2016;10:47–59.CrossRefPubMedPubMedCentral

14.

Furuta Y, Shinohara T, Sano K, et al. Molecular pathologic study of human papillomavirus infection in inverted papilloma and squamous cell carcinoma of the nasal cavities and paranasal sinuses. Laryngoscope. 1991;101:79–85.CrossRefPubMed

15.

Lesperance MM, Esclamado RM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope. 1995;105:178–83.CrossRefPubMed

16.

Nudell J, Chiosea S, Thompson LD. Carcinoma ex-Schneiderian papilloma (malignant transformation): a clinicopathologic and immunophenotypic study of 20 cases combined with a comprehensive review of the literature. Head Neck Pathol. 2014;8:269–86.CrossRefPubMedPubMedCentral

17.

Kaufman MR, Brandwein MS, Lawson W. Sinonasal papillomas: clinicopathologic review of 40 patients with inverted and oncocytic schneiderian papillomas. Laryngoscope. 2002;112:1372–7.CrossRefPubMed

18.

Christensen WN, Smith RR. Schneiderian papillomas: a clinicopathologic study of 67 cases. Hum Pathol. 1986;17:393–400.CrossRefPubMed

19.

Califano J, Koch W, Sidransky D, et al. Inverted sinonasal papilloma : a molecular genetic appraisal of its putative status as a Precursor to squamous cell carcinoma. Am J Pathol. 2000;156:333–7.CrossRefPubMedPubMedCentral

20.

Buchwald C, Lindeberg H, Pedersen BL, et al. Human papilloma virus and p53 expression in carcinomas associated with sinonasal papillomas: a Danish epidemiological study 1980–1998. Laryngoscope. 2001;111:1104–10.CrossRefPubMed

21.

Buchwald C, Franzmann MB, Jacobsen GK, et al. Human papillomavirus (HPV) in sinonasal papillomas: a study of 78 cases using in situ hybridization and polymerase chain reaction. Laryngoscope. 1995;105:66–71.CrossRefPubMed

22.

Vorasubin N, Vira D, Suh JD, et al. Schneiderian papillomas: comparative review of exophytic, oncocytic, and inverted types. Am J Rhinol Allergy. 2013;27:287–92.CrossRefPubMedPubMedCentral

23.

Lawson W, Schlecht NF, Brandwein-Gensler M. The role of the human papillomavirus in the pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence. Head Neck Pathol. 2008;2:49–59.CrossRefPubMedPubMedCentral

24.

Syrjanen KJ. HPV infections in benign and malignant sinonasal lesions. J Clin Pathol. 2003;56:174–81.CrossRefPubMedPubMedCentral

25.

Syrjanen S, Happonen RP, Virolainen E, et al. Detection of human papillomavirus (HPV) structural antigens and DNA types in inverted papillomas and squamous cell carcinomas of the nasal cavities and paranasal sinuses. Acta Otolaryngol. 1987;104:334–41.CrossRefPubMed

26.

Cheung FM, Lau TW, Cheung LK, et al. Schneiderian papillomas and carcinomas: a retrospective study with special reference to p53 and p16 tumor suppressor gene expression and association with HPV. Ear Nose Throat J. 2010;89:E5–12.PubMed

27.

Ukpo OC, Flanagan JJ, Ma XJ, et al. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35:1343–50.CrossRefPubMed

28.

Wang F, Flanagan J, Su N, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2012;14:22–9.CrossRefPubMedPubMedCentral

29.

Schache AG, Liloglou T, Risk JM, et al. Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. Br J Cancer. 2013;108:1332–9.CrossRefPubMedPubMedCentral

30.

Bishop JA, Ma XJ, Wang H, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36:1874–82.CrossRefPubMedPubMedCentral

31.

Kerr DA, Arora KS, Mahadevan KK, et al. Performance of a branch chain RNA in situ hybridization assay for the detection of high-risk human papillomavirus in head and neck squamous cell carcinoma. Am J Surg Pathol. 2015;39:1643–52.CrossRefPubMed

32.

Mirghani H, Casiraghi O, Amen F, et al. Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice. Mod Pathol. 2015;28:1518–27.CrossRef

33.

Rooper LM, Gandhi M, Bishop JA, et al. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization. Oral Oncol. 2016;55:11–6.CrossRef

34.

Rooper LM, Bishop JA, Westra WH. Transcriptionally active high-risk human papillomavirus is not a common etiologic agent in the malignant transformation of inverted schneiderian papillomas. Head Neck Pathol. 2017;In press.

35.

Stoddard DG Jr, Keeney MG, Gao G, et al. Transcriptional activity of HPV in inverted papilloma demonstrated by in situ hybridization for E6/E7 mRNA. Otolaryngol Head Neck Surg. 2015;152:752–8.CrossRef

36.

d’Errico A, Pasian S, Baratti A, et al. A case-control study on occupational risk factors for sino-nasal cancer. Occup Environ Med. 2009;66:448–55.

37.

Udager AM, Rolland DC, McHugh JB, et al. High-frequency targetable EGFR mutations in sinonasal squamous cell carcinomas arising from inverted sinonasal papilloma. Cancer Res. 2015;75:2600–6.CrossRef

38.

Udager AM, McHugh JB, Betz BL, et al. Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma. J Pathol. 2016;239:394–8.CrossRef

39.

Anari S, Carrie S. Sinonasal inverted papilloma: narrative review. J Laryngol Otol. 2010;124:705–15.

Title: OSPs and ESPs and ISPs, Oh My! An Update on Sinonasal (Schneiderian) Papillomas
Author: Justin A. Bishop
Publication date: 01-09-2017
Publisher: Springer US
Published in: Head and Neck Pathology / Issue 3/2017
Electronic ISSN: 1936-0568
DOI: https://doi.org/10.1007/s12105-017-0799-9

At a glance: The STEP trials

Springer Medicine

OSPs and ESPs and ISPs, Oh My! An Update on Sinonasal (Schneiderian) Papillomas

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

Intestinal-Type Adenocarcinoma: Classification, Immunophenotype, Molecular Features and Differential Diagnosis

Papillary Thyroid Carcinoma Cervical Lymph Node Metastasis with Cystic Change Differentiated from Congenital Cystic Lesions with the Assistance of Immunohistochemistry: A Case Study

Transcriptionally Active High-Risk Human Papillomavirus is Not a Common Etiologic Agent in the Malignant Transformation of Inverted Schneiderian Papillomas

The Great Mimicker: Metastatic Breast Carcinoma to the Head and Neck with Emphasis on Unusual Clinical and Pathologic Features

Multiple Oral Mucosal Hamartomas in a 34-Year Old Female

Sinonasal Renal Cell-Like Carcinoma: Case Report and Review of the Literature